Literature DB >> 14654528

Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma.

Won Kim1, Seung Oe Lim, Jong-Seo Kim, Young Hee Ryu, Ji-Yeon Byeon, Hie-Joon Kim, Yong-Il Kim, Jin Seok Heo, Young Min Park, Guhung Jung.   

Abstract

PURPOSE: Hepatocellular carcinoma (HCC) is one of the most common malignant cancers closely associated with chronic infection by the hepatitis B virus (HBV) or the hepatitis C virus (HCV) throughout the world. Differential expression of the proteome in HBV- and HCV-associated HCC was investigated to identify any useful biomarkers indicating virus-specific hepatocarcinogenesis. EXPERIMENTAL
DESIGN: Twenty-one pairs of specimens (tumorous and surrounding nontumorous liver tissues) were obtained from 21 HCC patients. They were divided into three HCC types by viral markers: 7 hepatitis B surface antigen-positive (B-type HCC), 7 anti-HCV-positive (C-type HCC), and 7 hepatitis B surface antigen-negative and anti-HCV-negative. Total proteins were analyzed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and alterations in the proteome were examined.
RESULTS: Sixty proteins were identified that show significant changes in the expression level between nontumorous and tumorous tissues. Among these, 14 proteins were commonly changed in all three of the HCC types, but 46 proteins showed a tendency of viral marker specificity.
CONCLUSIONS: The identified proteins were classified according to the viral factor as being involved in B-type and C-type HCC. These results suggest strongly that the expression pattern of proteome in HCC tissues is closely associated with etiologic factors. The different protein profiles between B-type and C-type HCC indicate that the pathogenetic mechanisms of hepatocarcinogenesis may be different according to the viral factor, HBV and HCV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654528

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  38 in total

1.  Can proteomics lead to the discovery of real biomarkers for HCC?

Authors:  Yasuhiro Kuramitsu
Journal:  World J Hepatol       Date:  2010-02-27

2.  Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.

Authors:  Seung-Oe Lim; Sung-Gyoo Park; Jun-Hi Yoo; Young-Min Park; Hie-Joon Kim; Kee-Taek Jang; Jae-Won Cho; Byung-Chul Yoo; Gu-Hung Jung; Cheol-Keun Park
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.

Authors:  Sarwat Fatima; Xiaoke Shi; Zesi Lin; Guo-qing Chen; Xiao-hua Pan; Justin Che-Yuen Wu; John W Ho; Nikki P Lee; Hengjun Gao; Ge Zhang; Aiping Lu; Zhao Xiang Bian
Journal:  Mol Oncol       Date:  2015-09-30       Impact factor: 6.603

4.  CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.

Authors:  Yuguang Ye; Mingzhu Yin; Bihui Huang; Yaqi Wang; Xia Li; Ge Lou
Journal:  Tumour Biol       Date:  2015-01-13

5.  miR-221 overexpression contributes to liver tumorigenesis.

Authors:  Pascal Pineau; Stefano Volinia; Katherine McJunkin; Agnès Marchio; Carlo Battiston; Benoît Terris; Vincenzo Mazzaferro; Scott W Lowe; Carlo M Croce; Anne Dejean
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

6.  The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Shuji Kanmura; Hirofumi Uto; Yuko Sato; Koutarou Kumagai; Fumisato Sasaki; Akihiro Moriuchi; Makoto Oketani; Akio Ido; Kenji Nagata; Katsuhiro Hayashi; Sherri O Stuver; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2009-12-09       Impact factor: 7.527

7.  A possible predictive marker of progression for hepatocellular carcinoma.

Authors:  Michele DI Stasio; Maria Grazia Volpe; Giovanni Colonna; Melissa Nazzaro; Miriam Polimeno; Stefania Scala; Giuseppe Castello; Susan Costantini
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

8.  Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.

Authors:  Zhenhua Hu; Jie Zhou; Haibo Wang; Min Zhang; Shaogang Li; Yuzhou Huang; Jian Wu; Zhiwei Li; Lin Zhou; Shusen Zheng
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells.

Authors:  Samil Jung; Soonduck Lee; Jayhee Lee; Chengping Li; Ji-Yeon Ohk; Hyeon-Kyung Jeong; Seungkyu Lee; Sangwoo Kim; Yunyeong Choi; Sunghak Kim; Heungwoo Lee; Myeong-Sok Lee
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

10.  Identification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS Analysis.

Authors:  Vadanasundari Vedarethinam; Karthik Dhanaraj; Ilavenil Soundherrajan; Ravikumar Sivanesan
Journal:  Indian J Clin Biochem       Date:  2015-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.